Although it’s still early days for water-related technology companies, opportunities are increasing
Despite the strength of the major international players, an Ottawa-based firm is one of the more intriguing plays
Although mediocre returns are expected to persist in 2008, there are some promising firms
The companies trading on the S&P/TSX information technology subindex are no longer indicative of the sector’s strength
The companies that came before them offer a lesson: diversify the customer base
Proposal allows a panel to consist of two members if an industry representative is unable to continue serving on the panel
The new entity will create a transatlantic rival to NYSE Euronext
Two Canadian start-ups, along with Roche and Pfizer itself, offer ways to invest in this market
Companies that use genetic engineering to seek cures are expected to begin catching up to the Big Pharma firms
Analysts like Cardiome Pharma and Æterna Zentaris because the firms have track records and products in late stages of testing